U.S. Blood Clot Retrieval Devices Market Revenue & Market Analysis, 2026-2035
The U.S. blood clot retrieval devices market was evaluated at USD 903.25 million in 2025 and is projected to grow at a CAGR of 13.8% from USD 1017.42 million in 2026 to USD 3253.73 million in 2035. The market expansion is primarily driven by the increasing prevalence of acute ischemic stroke, creating greater demand for timely clot removal procedures and advanced neurovascular interventions. Additionally, ongoing technological improvements in thrombectomy devices, favorable reimbursement policies for stroke care, and the growing availability of specialised stroke treatment facilities are supporting the growth of the U.S. blood clot retrieval devices market.
Market Overview
A 2021 U.S. study published in Stroke evaluated access to mechanical thrombectomy across 11 states covering approximately 80 million residents. The study found that fewer than 50% of ischemic stroke patients initially received care at facilities capable of performing thrombectomy, highlighting the growing importance of expanding access to blood clot retrieval procedures and advanced stroke treatment networks in the United States.
The U.S. blood clot retrieval devices market has grown steadily over the years, supported by continuous advancements in neurovascular intervention technologies, increasing adoption of mechanical thrombectomy procedures, and the expansion of specialised stroke care services across healthcare facilities. The introduction of next-generation clot retrieval systems with improved navigation and clot engagement capabilities has further strengthened market penetration and clinical adoption. For instance, in August 2023, Penumbra, Inc. received U.S. FDA clearance for its BMX81 Delivery Catheter, designed to enhance access and support during complex neurovascular procedures, contributing to market growth.
The U.S. blood clot retrieval devices market is projected to experience significant growth throughout the forecast period due to increasing investments in stroke care infrastructure, expanding access to advanced neurointerventional treatments, and the growing emphasis on rapid diagnosis and treatment of acute ischemic stroke. The rising integration of artificial intelligence and imaging technologies in stroke management is also contributing to market expansion. For instance, by 2035, U.S. healthcare providers are expected to further strengthen comprehensive stroke networks and expand access to thrombectomy services to improve patient outcomes.
U.S. Blood Clot Retrieval Devices Market Overview
Base Year Market Size (2025): USD 903.25 Million
CAGR: 13.8%
Forecast Year Market Size (2035): USD 3,253.73 Million
Major Players:
Stryker Corporation
Medtronic plc
Penumbra, Inc.
Johnson & Johnson (Cerenovus)
Terumo Corporation (MicroVention)
U.S. Blood Clot Retrieval Devices Market Trends
The U.S. blood clot retrieval devices market is evolving rapidly due to increasing emphasis on procedural efficiency in neurointerventional care, advancements in device design, and the growing focus on improving treatment performance in complex vascular anatomies.
· The increasing adoption of large-bore aspiration technologies is enabling clinicians to achieve faster clot removal while reducing procedural complexity.
· The growing development of flexible and trackable retrieval devices is improving navigation through tortuous blood vessels and enhancing procedural success rates.
· The rising use of radial artery access in neurovascular interventions is encouraging the introduction of devices compatible with alternative access approaches.
· The increasing focus on reducing procedure times is driving demand for integrated thrombectomy solutions that streamline workflow during clot retrieval procedures.
Collectively, these trends are expected to support the continued growth of the U.S. blood clot retrieval devices market by enhancing procedural efficiency, expanding treatment capabilities, and improving overall intervention performance.
U.S. Blood Clot Retrieval Devices Market Analysis
By Product Type
Stent Retrievers dominate the U.S. blood clot retrieval devices market due to their high effectiveness in clot extraction.
Based on product type, the U.S. blood clot retrieval devices market is categorised into stent retrievers, mechanical embolus removal devices, Penumbra blood clot retrieval devices, aspiration devices, and ultrasound assisted devices. The stent retrievers segment leads the market with the highest market share in 2025.
By Application
Cerebral Arteries dominate the U.S. blood clot retrieval devices market owing to the widespread use of thrombectomy in stroke treatment.
Based on application, the U.S. blood clot retrieval devices market is categorised into cerebral arteries, coronary arteries, and peripheral arteries. The cerebral arteries segment leads the market with the highest market share in 2025.
By End-use
Hospitals dominate the U.S. blood clot retrieval devices market due to their advanced neurointerventional capabilities.
Based on end-use, the U.S. blood clot retrieval devices market is categorised into hospitals, ambulatory surgical centers, specialty centers, and others. The hospitals segment leads the market with the highest market share in 2025.
Key Companies Profiled
The U.S. blood clot retrieval devices market features a competitive landscape with leading neurovascular and medical device companies competing through advanced thrombectomy technologies, extensive product portfolios, and continuous innovation in clot removal solutions. Key players such as Stryker Corporation, Medtronic plc, Penumbra, Inc., Johnson & Johnson (Cerenovus), and Terumo Corporation (MicroVention) hold a significant share of the market, supported by strong clinical adoption, broad distribution networks, and ongoing investment in neurovascular device development.
The market is highly competitive, with companies focusing on next-generation thrombectomy systems, enhanced procedural performance, physician training programs, and portfolio expansion to strengthen their market positions. The increasing demand for stroke intervention procedures, growing adoption of minimally invasive treatments, and continuous advancements in neurovascular technologies are further intensifying competition across the market.
U.S. Blood Clot Retrieval Devices Market Companies:
Some of the key companies operating in the U.S. Blood Clot Retrieval Devices Market include:
Abbott Laboratories
Acandis GmbH
AngioDynamics, Inc.
Argon Medical Devices, Inc.
Boston Scientific Corporation
Cook Medical Inc.
Inari Medical, Inc.
Johnson & Johnson (Cerenovus)
Medtronic plc
Merit Medical Systems, Inc.
MicroVention, Inc.
Penumbra, Inc.
Phenox GmbH
Stryker Corporation
Terumo Corporation
Market Segmentation
This study provides revenue growth and emerging trends across the U.S. levels from 2021 to 2035, segmenting the U.S. blood clot retrieval devices market by-
Product Type (Revenue in USD Million, 2021 - 2035)
Stent Retrievers
Mechanical Embolus Removal Devices
Penumbra Blood Clot Retrieval Devices
Aspiration Devices
Ultrasound Assisted Devices
Application (Revenue in USD Million, 2021 - 2035)
Cerebral Arteries
Coronary Arteries
Peripheral Arteries
End-use (Revenue in USD Million, 2021 – 2035)
Hospitals
Ambulatory Surgical Centers
Specialty Centers
Others
Table of Content
1. Methodology and Scope
1.1. Scope of the Study
1.1.1. Market Segmentation
1.1.2. Market Definition
1.1.3. Inclusions and Exclusions of the Study
1.2. Research Design
1.2.1. Base Year, Historical Data, and Forecast Period
1.2.2. Data Collection Methods
1.2.2.1. Secondary Sources
1.2.2.2. Primary Sources
1.2.3. Research Methodology
1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)
1.2.3.2. Volume-Price Approach (Bottom-up Approach)
1.2.3.3. Data Triangulation
1.2.4. Forecasting Model
1.3. Research Assumptions
1.4. Validation and Data Quality Control
1.5. List of Primary Sources
1.6. List of Secondary Sources
2. Executive Summary
2.1. Market Overview
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
3. Industry Outlook
3.1. Industry Ecosystem Analysis
3.2. Parent/ Ancillary Market Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints/ Challenges
3.3.3. Opportunities
3.4. Value Chain Analysis
3.5. Technology Roadmap
3.6. Porters Analysis
3.7. PESTLE Analysis
4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)
4.1. Stent Retrievers
4.2. Mechanical Embolus Removal Devices
4.3. Penumbra Blood Clot Retrieval Devices
4.4. Aspiration Devices
4.5. Ultrasound Assisted Devices
5. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)
5.1. Cerebral Arteries
5.2. Coronary Arteries
5.3. Peripheral Arteries
6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)
6.1. Hospitals
6.2. Ambulatory Surgical Centers
6.3. Specialty Centers
6.4. Others
7. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)
7.1.1. U.S.
7.1.1.1. U.S. Blood Clot Retrieval Devices Market Estimates and Forecasts to 2035 (USD Mn)
7.1.1.2. Market Dynamics
7.1.1.3. Competitive Landscape
7.1.1.4. Regulatory Framework
7.1.1.5. Reimbursement Scenario
8. Competitive Landscape
8.1. Company Market Share Analysis, 2025
8.2. Company Tier Structure
8.3. List of Major Suppliers, By Key Countries
8.4. Key Company Positioning Analysis
8.5. Company Profile
8.5.1. Abbott Laboratories
8.5.2. Acandis GmbH
8.5.3. AngioDynamics, Inc.
8.5.4. Argon Medical Devices, Inc.
8.5.5. Boston Scientific Corporation
8.5.6. Cook Medical Inc.
8.5.7. Inari Medical, Inc.
8.5.8. Johnson & Johnson (Cerenovus)
8.5.9. Medtronic plc
8.5.10. Merit Medical Systems, Inc.
8.5.11. MicroVention, Inc.
8.5.12. Penumbra, Inc.
8.5.13. Phenox GmbH
8.5.14. Stryker Corporation
8.5.15. Terumo Corporation
9. Analyst Perspective
10. Related Reports
Revolution Insights Briefs
Stay informed with updates on related market reports and key industry topics.